Annual ReportFiscal Year Ended Mar. 31, 2012
- To Our Stakeholders

- Introducing the New Management Structure

- Introducing the New Management

- Interview with the Chairman

- Corporate Governance

- Comments from Outside Directors

- President Hiroyuki Sasa Discusses the Medium-Term Vision: Back to Basics

- SPECIAL FEATURE ¶¶Òõpro Medical Technology

- At a Glance

- Medical Business

- Life Science & Industrial Business

- Imaging Business

- Information & Communication Business

- Others

- Intellectual Property Report

- Board of Directors, Corporate Auditors and Executive Officers

- Financial Highlights

- Financial Review

- Business Risks

- Consolidated Financial Statements

- Other Financial Data

- ¶¶Òõpro Group Companies

- Investor Information

- FY Ended Mar. 31, 2025
- FY Ended Mar. 31, 2024
- FY Ended Mar. 31, 2023
- FY Ended Mar. 31, 2022
- FY Ended Mar. 31, 2021
- FY Ended Mar. 31, 2020
- FY Ended Mar. 31, 2019
- FY Ended Mar. 31, 2018
- FY Ended Mar. 31, 2017
- FY Ended Mar. 31, 2016
- FY Ended Mar. 31, 2015
- FY Ended Mar. 31, 2014
- FY Ended Mar. 31, 2013
- FY Ended Mar. 31, 2012

